<div id="readability-page-1"><div>Healthcare stocks outperformed the broader market on Friday, with Eli Lilly , Johnson &amp; Johnson and AbbVie among the major names hitting fresh 52-week highs.The sector has quietly become one of the market's stronger performers in recent weeks. Healthcare stocks in the S&amp;P 500 have gained roughly 3% this year, outperforming the broader index in recent trading as investors rotate toward defensive sectors. The Health Care Select Sector SPDR ETF (XLV) has also climbed about 3% year to date.Big Pharma names including Lilly, J&amp;J, AbbVie and Merck have all approached or reached new highs. The VanEck Pharmaceutical ETF extended its winning streak after reports that the Trump administration had narrowed its shortlist for the next FDA commissioner.Biotech stocks also participated in the rally. Moderna , Biogen and Incyte reached 52-week highs as the SPDR Biotech ETF (XBI) posted a seventh straight session of gains amid renewed healthcare M&amp;A activity.</div></div>

BIIB

MRNA

Healthcare stocks outperformed the broader market, with Eli Lilly, Johnson & Johnson, and AbbVie hitting new 52-week highs. The sector gained roughly 3% year-to-date as investors rotated into defensive plays. Biotech names like Moderna and Biogen also reached highs, supported by renewed M&A activity and positive news regarding FDA commissioner selection.

GuruFocus

Biogen

Johnson & Johnson

Moderna

Abbvie

Eli Lilly

Defiance Daily Target 2X Long LLY ETF

Direxion Daily LLY Bull 2X Shares

Direxion Daily LLY Bear 1X Shares

Defiance Daily Target 2X Short LLY ETF

Defiance Daily Target 2X Long MRNA ETF

YieldMax MRNA Option Income Strategy ETF

S&P 500

Health Care Select Sector SPDR

Merck

VanEck Pharmaceutical ETF

Incyte

Lilly, J&J and AbbVie Hit New Highs